clinical trial · NCT06735833
MMA Embolization for Refractory Chronic Migraine
Cerenovus, Part of DePuy Synthes Products, Inc.·N/A·recruiting·n = 70
MigraineMiddle Meningeal Artery embolization
brief summary
This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.
started
Apr 23, 2025
primary completion
Dec 25, 2028
completion
May 15, 2029
last updated
Apr 17, 2026
official title
Feasibility Study to Evaluate the Initial Safety and Effectiveness of TRUFILL n-BCA Liquid Embolic System in Middle Meningeal Artery Embolization for the Preventive Treatment of Refractory Chronic Migraine
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol